Features & Compatibility
Cardiogen is a short synthetic tetrapeptide composed of Alanine, Glutamic Acid, Aspartic Acid and Arginine (Ala-Glu-Asp-Arg), abbreviated as AEDR.
It is primarily investigated in preclinical research involving cardiomyocyte activity, myocardial cellular signaling, fibroblast regulation and apoptosis-related pathways. Experimental studies have also examined its influence on cellular proliferation and p53 protein expression in myocardial tissue. Research reference
Variant:
20mg*10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
CJC1295+Ipamorelin
This research blend combines CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue
Glow
Glow is a three-component research peptide blend combining BPC-157, GHK-Cu and TB-500. The formula is designed for laboratory studies involving
Retatrutide
Retatrutide, also known as LY3437943, is an investigational peptide designed to act on three metabolic hormone receptors: GIP, GLP-1, and
Semaglutide
Semaglutide is a GLP-1 analogue and GLP-1 receptor agonist that selectively binds to and activates GLP-1 receptors. It is widely
TB500(Thymosin B4 Acetate)
TB-500 is a synthetic research peptide related to Thymosin Beta-4, a naturally occurring actin-binding peptide involved in cellular organization and
Tirzepatide
Tirzepatide is a modified peptide that acts as a dual agonist of the GIP and GLP-1 receptors. Its dual-receptor profile

Reviews
There are no reviews yet.